Physician

Llewelyn John Rao, MD

According to 2025 Medicare claims, Llewelyn Rao, MD (NPI: 1518165448) practices ophthalmology in the Cleveland, OH market, with the plurality of this provider's patient population coming from Cuyahoga, OH. This provider's primary affiliated billing organization is RETINA ASSOCIATES OF CLEVELAND, INC. (NPI: 1912991225; TIN: 34-1411937) and primary practice location at 44130-4823. Rao is affiliated with the Cleveland Clinic Medicare ACO, LLC (ACO ID: A2729), participating under the MSSP model.

Rao's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,653 traditional Medicare patients, billed 58,130 HCPCS/CPT codes, and received $4,341,910 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 1,319 prescription claims across 386 beneficiaries totaling $31,321 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 83 records totaling $131,712. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $1,926,015 to $4,341,910. Concurrently, Part D prescription costs have changed little. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,104	10,981	$1,926,015
2016	1,267	12,071	$2,159,351
2017	1,352	12,544	$2,379,808
2018	1,437	13,676	$2,367,123
2019	1,435	14,604	$2,608,795
2020	1,393	11,912	$2,151,120
2021	1,560	15,096	$3,043,038
2022	1,816	21,712	$3,342,976
2023	1,587	46,381	$3,704,857
2024	1,653	58,130	$4,341,910

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	198	608	$25,778
2016	250	760	$30,127
2017	315	884	$32,066
2018	342	1,028	$35,817
2019	367	1,027	$37,827
2020	326	1,022	$34,111
2021	348	994	$30,379
2022	331	1,107	$33,533
2023	320	1,096	$34,939
2024	386	1,319	$31,321

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
67028	Injection of drug into eye	474	2,107	$83
92014	Established patient complete exam of visual system	861	958	$76
92012	Established patient problem focused exam of visual system	422	1,225	$58
92134	Imaging of retina	1,434	3,840	$27
92202	Extended exam of the back part of the eye with optic nerve drawing	722	727	$10

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Prednisolone Acetate	Prednisolone Acetate	470	14,465	$12,742
Brimonidine Tartrate	Brimonidine Tartrate	77	3,161	$3,422
Ketorolac Tromethamine	Ketorolac Tromethamine	147	5,255	$2,404
Ofloxacin	Ofloxacin	199	4,426	$1,990
Latanoprost	Latanoprost	247	11,611	$1,711

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	55	$5,274	Genentech USA, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	28	$126,437	Apellis Pharmaceuticals, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Llewelyn John Rao, MD?

Tedicare shows public-source Medicare data for Llewelyn John Rao, MD (NPI 1518165448), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Llewelyn John Rao, MD have ACO affiliation data?

Llewelyn John Rao, MD is shown with ACO affiliation data for Cleveland Clinic Medicare ACO, LLC (MSSP, ACO ID A2729).

What billing organization is linked to Llewelyn John Rao, MD?

Llewelyn John Rao, MD is linked to RETINA ASSOCIATES OF CLEVELAND, INC. (billing NPI 1912991225) in the available physician profile data.

Does Llewelyn John Rao, MD have Open Payments data?

Llewelyn John Rao, MD has 83 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.